BioCatalystWatch
GANXWorkspace / GANX / OverviewCompany library
Gain Therapeutics, Inc. logo

Gain Therapeutics, Inc.

Gain Therapeutics, Inc. (GANX)

Website

Price
Market cap
Next catalystQ1 2027 initiation, following a comprehensive redesign and submission of new Phase 2 protocolRexaceract — planned Phase 2a early Parkinson’s disease study · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Rexaceract

GCase (β-glucocerebrosidase)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Rexaceract

GCase (β-glucocerebrosidase)

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Rexaceract

GCase (β-glucocerebrosidase)

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Rexaceract

GCase (β-glucocerebrosidase)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Rexaceract

GCase (β-glucocerebrosidase)

Rexaceract

GCase (β-glucocerebrosidase)

Rexaceract

GCase (β-glucocerebrosidase)

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

GANX PR & News

PR & News

GANX SEC archive